Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 461,225 | 425,888 | 460,094 | 933,234 | 82,447 |
| Marketable Securities | 583,675 | 654,502 | 684,579 | 227,921 | 237,203 |
| Receivables | 24,241 | 23,946 | 19,936 | 12,906 | 16,837 |
| Inventories | 24,599 | 18,276 | 17,985 | 16,268 | 14,230 |
| TOTAL | $1,101,134 | $1,129,805 | $1,189,136 | $1,195,952 | $355,587 |
| Non-Current Assets | |||||
| PPE Net | 32,504 | 31,119 | 25,000 | 24,207 | 24,899 |
| Intangibles | 820,953 | 822,739 | 0 | 0 | 0 |
| Other Non-Current Assets | 52,379 | 50,492 | 31,645 | 32,729 | 33,494 |
| TOTAL | $905,836 | $904,350 | $56,645 | $56,936 | $58,393 |
| Total Assets | $2,006,970 | $2,034,155 | $1,245,781 | $1,252,888 | $413,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,002 | 4,960 | 4,761 | 3,471 | 3,579 |
| Accrued Expenses | 36,261 | 30,820 | 22,907 | 14,672 | 17,350 |
| Other current liabilities | 5,759 | 2,927 | 3,587 | 1,539 | 4,519 |
| TOTAL | $71,709 | $55,608 | $45,433 | $33,737 | $38,502 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,977 | 9,773 | 9,534 | 9,607 | 8,722 |
| Other Non-Current Liabilities | 1,119,225 | 1,119,293 | 931,945 | 932,911 | 38,419 |
| TOTAL | $1,144,274 | $1,137,740 | $942,103 | $938,598 | $39,987 |
| Total Liabilities | $1,215,983 | $1,193,348 | $987,536 | $972,335 | $78,489 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 221,183 | 220,598 | 198,999 | 198,373 | 193,103 |
| Common Shares | 221 | 221 | 199 | 198 | 192 |
| Retained earnings | -1,218,092 | -1,148,763 | -1,165,305 | -1,124,304 | -1,036,869 |
| Other shareholders' equity | -1,087 | 27 | -6 | 74 | 85 |
| TOTAL | $790,987 | $840,807 | $258,245 | $280,553 | $335,491 |
| Total Liabilities And Equity | $2,006,970 | $2,034,155 | $1,245,781 | $1,252,888 | $413,980 |